GO terms related to TGF-β receptor activity are significantly enriched among the SIX1 downstream targets (Fig. 5e), which links TGF-β signalling via SMAD3 to the synaptic communication between neurons and glioma cells. This evidence concerns the gene SMAD3 and central nervous system cancer.